Questions: Metabolic Flux Analysis

Question 1

Why can't metabolite concentrations alone tell you the flux through a metabolic pathway?

• A. Because metabolite concentrations are technically impossible to measure accurately
• B. Because a metabolite pool at steady state has equal rates of production and consumption — the concentration reveals the pool size but not the throughput rate
• C. Because metabolites degrade too quickly to be measured
• D. Because flux only matters for non-steady-state conditions

Answer: (B)

At metabolic steady state, each metabolite's concentration is constant because its production rate equals its consumption rate. A large pool could have high flux (fast production and consumption) or low flux (slow production and consumption matched at a higher concentration due to enzyme kinetics). Concentration and flux are fundamentally different quantities — analogous to the water level in a bathtub (concentration) versus the flow rate through the faucet and drain (flux). You need dynamic measurements (like isotope tracing) to distinguish between different flux states that produce the same steady-state concentrations.

Question 2

13C metabolic flux analysis works by feeding cells uniformly labeled 13C-glucose and measuring which downstream metabolites become labeled.

• T. True
• F. False

Answer: True

This is the experimental basis of 13C-MFA. Cells are fed glucose where some or all carbon atoms are replaced with 13C. As the labeled carbon flows through glycolysis, the TCA cycle, and biosynthetic pathways, it generates characteristic labeling patterns (isotopomers) in downstream metabolites. Mass spectrometry measures the mass shift from 13C incorporation, and the pattern of labeling across different metabolites is computationally fit to a metabolic network model to infer the flux through each reaction. Different flux distributions produce different labeling patterns, so the isotopomer data constrains the flux solution.

Question 3

A cancer cell and a normal cell both have the same intracellular concentration of pyruvate. Can you conclude they have the same glycolytic flux?

• A. Yes — equal pyruvate concentration implies equal glycolytic output
• B. No — the cancer cell could have much higher glycolytic flux with equally high pyruvate consumption by lactate dehydrogenase, maintaining the same steady-state pyruvate pool
• C. Yes — pyruvate is the end product of glycolysis so its concentration directly reflects flux
• D. No — but only because cancer cells have defective pyruvate kinase

Answer: (B)

The Warburg effect in cancer involves dramatically increased glycolytic flux, but pyruvate concentration may not reflect this because lactate dehydrogenase (LDH) rapidly converts pyruvate to lactate. Both production and consumption of pyruvate are elevated, and the steady-state pool can remain similar. This is precisely why flux analysis (using 13C tracing) is necessary — it reveals the dramatically different metabolic throughput that concentration measurements alone would miss.